Login / Signup

Heterologous mRNA vaccine booster increases neutralization of SARS-CoV-2 Omicron BA.2 variant.

Gen LiZhongcheng ZhouPeng DuMeixiao ZhanNing LiXinxin XiongShengjun TangMiao ManDaniel T Baptista-HonLigong Lu
Published in: Signal transduction and targeted therapy (2022)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • binding protein
  • saccharomyces cerevisiae
  • coronavirus disease